| 申请日期 | 2025-06-27 | 申请号 | CA2315397 |
| 公开（公告）号 | CA2315397C | 公开（公告）日 | 2007-08-07 |
| 公开国别 | CA | 申请人省市代码 | 全国 |
| 申请人 | MERCK CO INC | ||
| 简介 | Substituted 5-aryl-2, 4-thiazolidinediones are potent agonists of PPAR, and a re therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia a nd hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR .alpha., .delta. and/or .gamma. mediated diseases , disorders and conditions. | ||
|
您还没有登录，请登录后查看下载地址
|
客服热线：
手机版
二维码
